Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history now includes Revision: v3.4.2; the funding-status notice and Revision: v3.4.1 entry were removed.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and operating-status information, directing users to cc.nih.gov and opm.gov for updates. The history now shows Revision: v3.4.1 and removes Revision: v3.4.0.SummaryDifference0.6%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and visual color coding for changes (green for additions, red for deletions). Updated footer notes to Revision: v3.4.0 and adjusted the 'No FEAR Act Data' wording.SummaryDifference0.8%

- Check42 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) and removal of the previous revision (v3.3.3). These changes reflect internal site version updates and do not alter trial data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedThe history now shows a new revision entry, v3.3.2, replacing v3.3.1.SummaryDifference0.1%

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.